Dec. 04, 2012 |
|
Dec. 17, 2018 |
|
jRCT2080221972 |
Phase 2 Study to Evaluate Safety and Pharmacodynamics of CS-3150 in Type 2 Diabetes Mellitus Patients with Albuminuria |
|
version: date: |
DAIICHISANKYO Co.,Ltd. |
||
http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html |
||
Interventional |
||
2 |
||
Main Inclusion Criteria; |
||
Main Exclusion Criteria; |
||
30age old over | ||
70age old under | ||
Both |
||
Type 2 Diabetes Mellitus |
||
investigational material(s) |
||
DAIICHISANKYO Co.,Ltd. | |
JapicCTI-122018 | |